{"url_path":"/sec/cik-0001697884/10-k/2026/item-5","section_key":"item-5","section_title":"Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1697884/0001640334-26-001082-index.html","accession_number":"0001640334-26-001082","cik":"0001697884","ticker":null,"issuer_name":"VITASPRING BIOMEDICAL CO. LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1697884/0001640334-26-001082-index.html","primary_entity_key":"0001697884","primary_entity_name":"VITASPRING BIOMEDICAL CO. LTD."},"word_count":600,"has_tables":true,"body_markdown":"**Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.**\n\n \n\n**Market Information**\n\n \n\nOur common stock is quoted on the OTC Pink marketplace under the symbol “VSBC.” The OTC Pink is a decentralized, quotation-driven market operated by OTC Markets Group, Inc. Because this market is not a national securities exchange, the prices quoted for our stock may not reflect actual trading transactions or represent reliable market values. Quotes are inter-dealer quotations without retail markup.\n\n \n\nThere is very limited public trading in our common stock. During the fiscal years ended January 31, 2026, and January 31, 2025, trading volume was minimal, and no consistent bid or ask quotations were reported. The high and low bid quotations presented below reflect limited market activity and may not represent actual trading prices or an active market for our common stock.\n\n \n\n \n\n \n\n**High**\n\n \n\n \n\n**Low**\n\n \n\n**Fiscal Quarters for the Fiscal Year ended January 31, 2026(1)**\n\n \n\n \n\n \n\n \n\n \n\n \n\nJanuary 31, 2026\n\n \n\n$\n\n1.00\n\n \n\n \n\n$\n\n1.00\n\n \n\nOctober 31, 2025\n\n \n\n$\n\n1.00\n\n \n\n \n\n$\n\n1.00\n\n \n\nJuly 31, 2025\n\n \n\n$\n\n1.00\n\n \n\n \n\n$\n\n1.00\n\n \n\nApril 30, 2025\n\n \n\n$\n\n1.00\n\n \n\n \n\n$\n\n0.15\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**Fiscal Quarters for the Fiscal Year Ended January 31, 2025**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nJanuary 31, 2025\n\n \n\n$\n\n16.00\n\n \n\n \n\n$\n\n0.10\n\n \n\nOctober 31, 2024\n\n \n\n$\n\n16.00\n\n \n\n \n\n$\n\n16.00\n\n \n\nJuly 31, 2024\n\n \n\n$\n\n16.00\n\n \n\n \n\n$\n\n16.00\n\n \n\nApril 30, 2024\n\n \n\n$\n\n16.00\n\n \n\n \n\n$\n\n16.00\n\n \n\n \n\nBecause our stock trades infrequently and with low volume, investors may have difficulty buying or selling shares at desired prices or at all. We make no representation that an active or liquid trading market exists or will develop in the future.\n\n \n\nAs of January 31, 2026, there were approximately 703 shareholders of record of our common stock. This number does not include beneficial owners who hold their shares in “street name” through brokerage firms or other nominees.\n\n \n\nAs of June 17, 2026, we had 207,030,030 shares of common stock issued and outstanding held by 708 shareholders.\n\n \n\n**Dividends**\n\n \n\nWe have never declared or paid dividends on our common stock and do not expect to pay dividends in the foreseeable future. Our sole director will decide whether to declare dividends in the future, and that decision will depend on many factors, including our earnings, cash needs, financial condition, capital requirements, legal and contractual restrictions, and any other factors our sole director considers relevant.\n\n \n\nAt this time, we plan to retain any available funds and future earnings to support the growth and development of our business. As a result, investors should not expect to receive cash dividends on our common stock in the near term.\n\n \n\nThere can be no assurance that we will ever declare or pay cash dividends on our common stock.\n\n \n\n \n\n17\n\n*Table of Contents*\n\n \n\n**Recent Sales of Unregistered Securities**\n\n \n\nWe did not issue any unregistered equity securities during the fiscal year ended January 31, 2026.\n\n \n\n**Transfer Agent**\n\n \n\nOur transfer agent is Empire Stock Transfer, Inc., located at 1859 Whitney Mesa Dr., Henderson, NV 89014. They can be reached by telephone at (702) 818-5898 or by facsimile at (702) 974-1444.\n\n \n\n**Additional Information**\n\n \n\nCopies of our annual reports on Form 10−K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports filed with the Securities and Exchange Commission (“SEC”) are available free of charge through the SEC’s website at www.sec.gov. These filings are accessible as soon as reasonably practicable after we electronically file or furnish them with the SEC.\n\n \n\nThe information contained in our filings, including any forward-looking statements, is made as of the date of the respective documents. We do not undertake any obligation to update such statements or documents, except as required by applicable law."}